MIa is currently working to provide elesclomol-copper treatments worldwide for the clinical teams of Menkes patients who obtain authorizations for exceptional treatments at their hospitals and national medicines agencies. There are currently 3 cases ongoing in Spain, and several new cases about to start.

CORE is the functional structure of Menkes International that coordinates exceptional treatments for Menkes disease under the leadership of Dr Francesc Palau, Physician and Researcher at the Sant Joan de Déu Children’s Hospital in Barcelona. The members are as follows:

Pediatrician and Clinical Geneticist, Head Dept. of Genetic Medicine, Hospital Sant Joan de Déu, and NeuroGene Senior Investigator, SJD Research Institute and CIBERER.

Pediatrician, Clinical advisor, Pediatric Complex Chronic patient and Palliative care unit, Regional University Hospital of Malaga, Biomedical Research Institute of Málaga.

Neurological Pediatric Physiotherapist and Trainer Head of Clinical Pediatric Physiotherapist Teams

Clinical Investigator, Neurogenetics & Molecular Medicine Research Group (NeuroGene), Sant Joan de Déu Research Institute

Menkes International Executive Secretary